Actavis Mid Atlantic Company Profile
What is the competitive landscape for ACTAVIS MID ATLANTIC
ACTAVIS MID ATLANTIC has sixty approved drugs.
Summary for Actavis Mid Atlantic
| US Patents: | 0 |
| Tradenames: | 48 |
| Ingredients: | 45 |
| NDAs: | 60 |
| Patent Litigation for Actavis Mid Atlantic: | See patent lawsuits for Actavis Mid Atlantic |
Drugs and US Patents for Actavis Mid Atlantic
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | ACETASOL HC | acetic acid, glacial; hydrocortisone | SOLUTION/DROPS;OTIC | 087143-001 | Jan 13, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Actavis Mid Atlantic | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | homatropine methylbromide; hydrocodone bitartrate | SYRUP;ORAL | 088017-001 | Jul 5, 1983 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Actavis Mid Atlantic | PROMETH PLAIN | promethazine hydrochloride | SYRUP;ORAL | 085953-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Actavis Mid Atlantic | PHENYTOIN | phenytoin | SUSPENSION;ORAL | 089892-001 | Sep 25, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
